DRD Biotech

About:

DRD developing rapid diagnostic test for the brain damage: Stroke, Concussion.

Twitter/X: drdbiotech

Description:

Developing a rapid diagnostic test for the brain damage such as Ischemic Stroke, Transient Ischemic Attack, Mild Traumatic Brain Injury, Post-Traumatic Epilepsy, Chronic Brian Ischemia.

Total Funding Amount:

150M RUB

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Moscow, Moscow City, Russian Federation

Founded Date:

2014-09-05

Contact Email:

office(AT)drdbiotech.ru

Founders:

Number of Employees:

11-50

Last Funding Date:

2016-01-01

IPO Status:

Private

Industries: